Gan & Lee Pharmaceuticals. (SHA:603087)

China flag China · Delayed Price · Currency is CNY
46.30
-0.22 (-0.47%)
Apr 2, 2025, 2:45 PM CST
15.52%
Market Cap 27.78B
Revenue (ttm) 2.95B
Net Income (ttm) 580.86M
Shares Out 597.09M
EPS (ttm) 0.99
PE Ratio 47.18
Forward PE 31.65
Dividend 0.50 (1.11%)
Ex-Dividend Date Dec 2, 2024
Volume 6,581,548
Average Volume 8,154,996
Open 46.50
Previous Close 46.52
Day's Range 46.18 - 46.89
52-Week Range 37.63 - 53.67
Beta 1.59
RSI 57.76
Earnings Date Apr 25, 2025

About SHA:603087

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China. The company’s products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro and lispro mix 75/25 injection; Prandilin 25, an insulin lispro injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection. It also offers GanleePen, an insulin injection device; ... [Read more]

Sector Healthcare
Founded 1998
Employees 4,482
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603087
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.